Another important area for further study is to refine the estimation of risk in women whose 36 wkGA assessment identified them as being at intermediate risk (5%–6%) of severe preeclampsia, namely, women with an sFlt-1:PlGF ratio >38 and no risk factors or risk factors but a ratio of ≤38. This evidence concerns the gene PGF and preeclampsia.